Drawing for INTERCELL SMART VACCINES

USPTO serial 78167815

INTERCELL SMART VACCINES

Reviewed by CopyMark Law Group

Reg. 2888858Status 710
Filing date
Status date
Registration date
Sep 28, 2004
Examiner
BERK, STEVEN R
Law office
TMEG LAW OFFICE 102

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INTERCELL SMART VACCINES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David Ehrlich

David Ehrlich Fross Zelnick Lehrman & Zissu, P.C.4 TIMES SQUARE, 17TH FLOORNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ chemicals for use in the pharmaceutical industry to manufacture diagnostic and therapeutic biological products for diagnosis, treatment, and monitoring of cancers, infectious diseases and other chronic diseases ]SECTION 8 - CANCELLED—
005vaccines [ and bio-pharmaceutical preparations ] for use in human [ and veterinary ] medicine, namely, for the treatment of [ cancers, ] infectious diseases and other chronic diseases, namely, Encephalitis, [ Hepatitis C, Tuberculosis, bladder cancer, travellers' diarrhea and Streptococci; diagnostic and therapeutic biological pharmaceutical preparations for diagnosis, treatment and monitoring of cancer, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travellers' diarrhea and Streptococci ]SECTION 8 - CANCELLED—
009[ scientific apparatus used for diagnosis, treatment and monitoring of cancer, infectious diseases and other chronic diseases, namely, test tubes, microscopes, and retorts ]SECTION 8 - CANCELLED—
010[ surgical and medical instruments and apparatus for use in medical analysis and blood testing namely, bougies, cannulae, injectors, probes, scalpels ]SECTION 8 - CANCELLED—
042[ product research and development, namely, development of medical test methods; chemical, medical, pharmaceutical and bacterialogical research ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 11, 2025CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Apr 5, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2014ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 23, 2014NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED—
Sep 23, 2014RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Sep 23, 20149G8PREGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8—
Sep 23, 20148PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
Sep 19, 2014E89RTEAS SECTION 8 & 9 RECEIVED—
Mar 19, 20118.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Mar 18, 2011APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 15, 20118.AFREGISTERED - SEC. 8 (6-YR) FILED—
Mar 15, 2011ES8RTEAS SECTION 8 RECEIVED—
Sep 28, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 6, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 16, 2004NPUBNOTICE OF PUBLICATION—
May 3, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 200444DDSEC. 44(D) CLAIM DELETED—
Mar 18, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 2004MAILPAPER RECEIVED—
Mar 2, 2004CNSLLETTER OF SUSPENSION MAILED—
Mar 2, 2004CNEAEXAMINERS AMENDMENT MAILED—
Feb 24, 2004CNSLLETTER OF SUSPENSION MAILED—
Feb 11, 2004MAILPAPER RECEIVED—
Feb 5, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 5, 2004MAILPAPER RECEIVED—
Dec 12, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2003CNSLLETTER OF SUSPENSION MAILED—
Oct 20, 2003DOCKASSIGNED TO EXAMINER—
Oct 6, 2003CFITCASE FILE IN TICRS—
Sep 8, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 8, 2003MAILPAPER RECEIVED—
Sep 5, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance